List of corporate sponsors

We thank our corporate sponsors for making the work of fighting kidney disease on all fronts possible. These organizations help ensure that every kidney patient has access to health care and every person at risk for this chronic health condition is empowered to prevent it.

Thank you to our major corporate sponsors

The following sponsors supported the programs and services of the American Kidney Fund with generous contributions of $5,000 or more. You can also view our Corporate Members here.

($500,000+)

AstraZeneca Pharmaceuticals LP

GlaxoSmithKline

($100,000–$499,999)

Akebia Therapeutics, Inc.

Alnylam Pharmaceuticals, Inc.

Amgen USA

Cara Therapeutics

DaVita Healthcare Partners, Inc

FMC Renal Pharmaceuticals

Horizon Therapeutics

Otsuka America Pharmaceutical Inc.

Tricida Inc

Vertex, Inc.

($50,000–$99,999)

Abbott Nutrition

Alexion Pharmaceuticals, Inc.

Ardelyx, Inc.

Rockpointe Corporation

Satellite Healthcare Inc

Truist Foundation - formerly Suntrust

($25,000–$49,999)

Gentian

Quest Diagnostics

Relypsa, Inc.

Right Advisory LLC

Travere

($5,000–$24,999)

American Society of Nephrology

Apellis Pharmaceuticals, Inc.

Aurinia Biotechnology Innovation Organization (BIO)

ColorNet Printing & Graphics

Dime Community Bank

EventEQ

Federal Street Strategies LLC

Flushing Bank

Fresenius Medical Care Institute for Advanced Clinical Trials for Children

Interactive Strategies

Jaspan Schlesinger LLP

JPA Health Communications

King & Spalding LLP

Latham & Watkins

Mallinckrodt Inc.

Mercury Public Affairs

Natera

National Renal Administrators Association

Northleaf Capital Partners

Omeros Corporation

OPKO Health - Renal Division

Orases PhRMA

PROTEK Consulting

RKD Group

Rockwell Medical Technologies Inc

Satter Investment Management

SPG Fiduciary Partners of Raymond James

Spherix Global Insights

SplitOak Strategies LLC

The Cooking Doc, LLC

The Meltzer Group NFP

Vendorin York Studios

Pharmaceutical Funding

The total pharmaceutical revenue including donated product is $5,361,700
The percentage of revenue from pharmaceutical companies is 1.59%

Note: Compliance with the U.S. Department of Health and Human Services Office of the Inspector General Opinion 97-1, under which the HIPP program operates, prohibits HIPP (Health Insurance Premium Program) donors to be included in this list.